Blood Res.
2013 Sep;48(3):233-234. 10.5045/br.2013.48.3.233.
Relationship between bortezomib-containing regimens and the incidence of tuberculosis in patients with myeloma
- Affiliations
-
- 1Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. kihyunkimk@gmail.com
- 2Department of Internal Medicine, Kyung Hee University Hospital, Seoul, Korea.
- KMID: 2270714
- DOI: http://doi.org/10.5045/br.2013.48.3.233
Abstract
- No abstract available.
MeSH Terms
Reference
-
1. Nucci M, Anaissie E. Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents. Clin Infect Dis. 2009; 49:1211–1225. PMID: 19769539.
Article2. Ahn JS, Rew SY, Yang DH, et al. Poor prognostic significance of Mycobacterium tuberculosis infection during bortezomib-containing chemotherapy in patients with multiple myeloma. Blood Res. 2013; 48:35–39. PMID: 23589793.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Poor prognostic significance of Mycobacterium tuberculosis infection during bortezomib-containing chemotherapy in patients with multiple myeloma
- Bortezomib-induced Histiocytoid Sweet Syndrome
- A Case of Acute Pancreatitis Caused by Bortezomib in a Patient with Multiple Myeloma
- Reversible Heart Failure after Bortezomib Treatment in a Patient with Multiple Myeloma
- Huge Cutaneous Involvement of Multiple Myeloma
